Endologix
Founded Year
1992Stage
Take Private | AliveTotal Raised
$177.5MRevenue
$0000About Endologix
Endologix is a company focused on the development and manufacturing of minimally invasive treatments for aortic disorders, operating within the medical devices industry. The company's main offerings include a variety of endovascular stent grafts, which are used for the treatment of abdominal aortic aneurysms (AAA), a condition characterized by a weakening of the wall of the aorta that can lead to a balloon-like enlargement. Endologix primarily serves the healthcare sector, particularly in areas related to vascular disease and aortic disorders. It was founded in 1992 and is based in Irvine, California.
Loading...
Loading...
Endologix Patents
Endologix has filed 83 patents.
The 3 most popular patent topics include:
- vascular diseases
- diseases of the aorta
- vascular surgery
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
8/23/2019 | 10/17/2023 | Vascular diseases, Prosthetics, Implants (medicine), Diseases of the aorta, Vascular surgery | Grant |
Application Date | 8/23/2019 |
|---|---|
Grant Date | 10/17/2023 |
Title | |
Related Topics | Vascular diseases, Prosthetics, Implants (medicine), Diseases of the aorta, Vascular surgery |
Status | Grant |
Latest Endologix News
Nov 9, 2023
IRVINE, Calif.--(BUSINESS WIRE)--Endologix LLC, a privately held, global medical device company dedicated to providing disruptive therapies for the interventional treatment of vascular disease, announced today that the company will be presenting in two upcoming healthcare conferences: The 2023 Stifel Healthcare Conference Wednesday, November 15, 2023, at 10:55 AM Eastern Time. Canaccord Genuity Medical Technology and Diagnostics Forum Thursday, November 16, 2023, at 9:30 AM Eastern Time. About
Endologix Frequently Asked Questions (FAQ)
When was Endologix founded?
Endologix was founded in 1992.
Where is Endologix's headquarters?
Endologix's headquarters is located at 2 Musick, Irvine.
What is Endologix's latest funding round?
Endologix's latest funding round is Take Private.
How much did Endologix raise?
Endologix raised a total of $177.5M.
Who are the investors of Endologix?
Investors of Endologix include Deerfield Management, Paycheck Protection Program, EW Healthcare Partners, Epic Ventures, Wasatch Advisors and 6 more.
Who are Endologix's competitors?
Competitors of Endologix include MicroTransponder, Vertos Medical, Gynesonics, Monteris Medical, Reva Medical and 7 more.
Loading...
Compare Endologix to Competitors
Varix Medical Corporation, located in Sunnyvale, Calif., is a medical device company focused on developing products for the minimally invasive treatment of chronic venous insufficiency, commonly referred to as "varicose veins." For patients with advanced stages of varicose veins, laser- and RF-based (radiofrequency) treatments have been developed, but each device has deficiencies making them less-than-optimal solutions. Varix Medical's platform technology will enable physicians to efficiently and effectively treat more types of diseased veins than is currently possible when using either laser or RF devices. Additional treatable vessels include tortuous sub-truncal vessels and other visible smaller varicose veins. The Varix platform employs a vapor-based endovenous ablation system that will consist of a disposable catheter, a catheter introducer or delivery system, and a reusable vapor generator. RCT and Coronis Medical Ventures LLC., formed Varix in August 2007 and acquired the technology under license from Tsunami MedTech LLC. Coronis and RCT have been the primary in investors in Varix.
Intersect Partners is a California based medical devices company. The company primarily produces intragastric balloons, stent-like neurological medical devices, and associated minimally invasive drug delivery and device systems.
TriReme Medical is a privately held medical device company dedicated to the development, manufacturing, and commercialization of next generation percutaneous devices for the treatment of complex coronary and peripheral arterial disease. The company is focused on the US and the emerging Asian markets.
Researcher and developer of a minimally invasive, encapsulated cellular transplant device for the treatment of diabetes. The company sold its assets to Novocell.
Monteris Medical is a neurosurgical company that operates in the healthcare industry. The company offers a minimally invasive, robotically controlled laser thermal therapy system that uses MRI-guided laser light to destroy unwanted tissue in the brain, such as tumors and lesions. Monteris primarily serves the healthcare sector, particularly neurosurgery. It was founded in 1999 and is based in Hopkins, Minnesota.
DuoCure offers intraluminal minimally invasive implantable device for treatment of obesity.
Loading...